Cocrystal Pharma Inc (COCP)

[usasingh1]

In March 2015, the Company accepted Securities Purchase Agreements representing investor commitments totaling $15,000,000 in a private
placement offering of 16,304,350 shares of the Company’s common stock at a purchase price of $0.92 per share. The purchasers included all
seven members of the Board and Dr. Roger Kornberg, the Company’s Chief Scientist.
On March 9, 2016, the Company sold $5,004,370 of shares of common stock in a private placement offering to investors who participated in
the March 2015 private placement on a pro-rata basis to their participation in the March 2015 private placement. The Company sold
9,812,491 shares of the Company’s common stock at a purchase price of $0.51 per share. The purchasers included all seven members of the
Board